Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tissue factor expression and angiogenesis in human prostate carcinoma.

S A Abdulkadir1, G F Carvalhal, Z Kaleem

  • 1Department of Pathology, Washington University School of Medicine, St Louis, MO 63110, USA.

Human Pathology
|May 23, 2000
PubMed
Summary

Tissue factor (TF) promotes prostate cancer growth by increasing blood vessel formation (angiogenesis) and is linked to higher PSA levels. This suggests TF plays a key role in prostate cancer progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer.

Nature communications·2020
Same author

Acquired Resistance to Poly (ADP-ribose) Polymerase Inhibitor Olaparib in <i>BRCA2</i>-Associated Prostate Cancer Resulting From Biallelic <i>BRCA2</i> Reversion Mutations Restores Both Germline and Somatic Loss-of-Function Mutations.

JCO precision oncology·2019
Same author

PRES with asymptomatic spinal cord involvement. Is this scenario more common than we know?

Spinal cord series and cases·2017
Same author

Fulminant type 1 diabetes caused by dual immune checkpoint blockade in metastatic renal cell carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

[The 2014 consensus conference of the ISUP on Gleason grading of prostatic carcinoma].

Der Pathologe·2016
Same author

NFATc1 promotes prostate tumorigenesis and overcomes PTEN loss-induced senescence.

Oncogene·2015

Area of Science:

  • Oncology
  • Vascular Biology
  • Biochemistry

Background:

  • Tumor growth relies on angiogenesis, regulated by angiogenic factors.
  • Tissue factor (TF) influences angiogenesis by modulating growth factors like VEGF and anti-angiogenic molecules.

Purpose of the Study:

  • To investigate TF expression in prostate cancer.
  • To determine the relationship between TF, angiogenesis, and tumor progression in prostate carcinomas.

Main Methods:

  • Immunohistochemical analysis of TF expression in prostate carcinoma specimens.
  • Correlation analysis of TF expression with microvessel density (MVD) and preoperative PSA levels.

Main Results:

  • High TF levels were observed in 73% of prostate carcinoma specimens, localized to malignant epithelial cells.

Related Experiment Videos

  • TF expression significantly correlated with increased MVD, indicating enhanced tumor angiogenesis.
  • TF expression was also correlated with higher preoperative PSA levels, a marker for recurrence.

    • Conclusions:

    • TF expression is common in prostate cancer epithelial cells.
    • TF may regulate prostate cancer progression and angiogenesis.
    • TF is a potential therapeutic target for managing prostate cancer.